Plötsligt händer det.
Ett mejl jag hoppas på. Men inte varit säker på.
EFFECTS är accepterad som muntlig presentation vid European Stroke Organisation and World Stroke Organization Conference (ESO-WSO 2020).
Tid: Onsdagen den 13 maj. Klockan 11:30. Detaljer se nedan. Man har 9 minuter på sig att presentera studien. Det är ungefär 1 minut per år studien pågick.
Dagen innan har vi ett prövarmöte för dig som medprövare. Vi har tyvärr ingen möjlighet att sponsra resa eller uppehälle detta år. Trots det hoppas vi på ett 30-talet deltagare.
Om du är med på detta möte kommer du att kunna ta del av resultet i förväg, under förutsättning att du skriver på ett sekretess-avtal.
Ett stort tack till alla medprövare. För att ni gjorde denna studie möjlig.
Nu har vi snart ett resultat att offentliggöra. Från: ESO_WSO Skickat: den 4 mars 2020 12:07 Till: Erik Lundström Ämne: ESO-WSO 2020 - Abstract Acceptance - Plenary Oral Presentation
Dear Dr. Erik Lundström,
On behalf of the Scientific Abstract Committee, we are delighted to confirm that your abstract has been selected for Oral Presentation at the forthcomingjoint European Stroke Organisation and World Stroke Organization Conference (ESO-WSO 2020), to be held in Vienna, Austria on 12-15 May 2020.
Abstract Number: 210 Abstract Title: EFFICACY OF FLUOXETINE – A RANDOMIZED CONTROLLED TRIAL IN STROKE (EFFECTS)
Your abstract was among a handful that received the top average scores from several independent, blinded reviewers and is selected for presentation in one of the conferences Plenary Sessions.
Please see your session details:
Session Title: Plenary 01: Official Welcome & Large Clinical Trials Session Date: 05-13-2020 Session Time: 10:45 AM - 12:30 PM Hall Name: Hall A Presentation Start Time: 11:30
Oral presentations are currently scheduled at 10-minute intervals, (1 minute for introduction by the chairs, 9 minutes for presentation). It is very important that you adhere to this format to ensure the session runs as scheduled.
Participants will have the opportunity to view abstracts via the Conference website and the Mobile App during the Conference.
As the author of a high-profile abstract, you will be contacted by one of our scientific committee members to assist with drafting a press release and asked to cooperate with the PR team. This might involve a request to record a short video interview summarising your work which will be placed on the conference website. We will carefully respect confidentiality and any embargo on results that you can share to maximise the impact of your presentation.
